BPMC | Blueprint Medicines Corp
Category: Consumer goods
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 2.97B Prev closed: 75.26 Open: 74.64 High: 75.42 Low: 73.72 52 week low: 43.29 52 week high: 87.43 Dividends: No Dividends Next ER: August 2, 2023
Company Profile We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, healthier lives. Our approach combines our leading expertise in protein kinases with sound execution and an intense focus on discovery.
We maintain a diverse and growing portfolio of research programs, moving multiple investigational medicines through clinical development for patients with a broad range of genomically defined cancers and rare diseases.
Earnings History Date EPS / Forecast Revenue / Forecast October 26, 2023 August 2, 2023 -2.19 / -2.5557.57M / 45.08MBeat! May 4, 2023 -2.15 / -2.6563.3M / 41.85MBeat! February 16, 2023 -2.65 / -2.6338.78M / 34.16MBeat! November 1, 2022 -2.23 / -2.4965.98M / 43.51MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jul 28, 2023 63.12 60.67 64.03
60.67
721K 5.66% Jul 27, 2023 59.74 59.91 60.75
58.92
596K 1.08% Jul 26, 2023 59.1 59.13 60.27
58.71
622K 0.41% Jul 25, 2023 58.86 57.62 59.35
57.47
896K 1.82% Jul 24, 2023 57.81 58.26 58.67
57.15
578K -0.57% Jul 21, 2023 58.14 58.41 58.74
57.67
876K -0.45% Jul 20, 2023 58.4 57.55 58.96
57.32
507K 1.44% Jul 19, 2023 57.57 57.54 58.45
57.43
517K 0.51% Jul 18, 2023 57.28 57.84 58.51
57.27
394K -1.05% Jul 17, 2023 57.89 57.8 59.09
57.31
372K 0.49% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2008 Employees:394 News
The Petri Dish: Blueprint hit with clinical hold, Moderna to set up patient assistance program finance.yahoo.com Aug 1, 2023 9:22 am
Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates finance.yahoo.com Aug 1, 2023 8:25 am
Blueprint Medicines Announces Partial Clinical Hold for Phase 1/2 VELA Trial of BLU-222 finance.yahoo.com Aug 1, 2023 8:00 am
Blueprint Medicines to Regain Global Rights to GAVRETO® (pralsetinib) from Roche finance.yahoo.com Aug 1, 2023 8:00 am
Strength Seen in Fate Therapeutics (FATE): Can Its 9.3% Jump Turn into More Strength? finance.yahoo.com Aug 1, 2023 7:40 am
Blueprint Medicines Reports Fourth Quarter and Full Year 2022 Results finance.yahoo.com Aug 1, 2023 7:00 am Blueprint Medicines says partner Genentech withdraws use of Gavreto for thyroid cancer finance.yahoo.com Aug 1, 2023 6:26 am
Blueprint Medicines (NASDAQ:BPMC) investors are sitting on a loss of 24% if they invested five years ago finance.yahoo.com Jun 9, 2023 9:22 am
This Biotech Could Soon Go Parabolic, But Should You Buy It? finance.yahoo.com Jun 4, 2023 8:45 am
Blueprint's (BPMC) Q1 Earnings & Sales Top Estimates, View Up finance.yahoo.com May 5, 2023 6:54 am
Shareholders in Blueprint Medicines (NASDAQ:BPMC) are in the red if they invested a year ago finance.yahoo.com Dec 31, 2022 7:25 am
Blueprint Medicines Reports First Quarter 2023 Results finance.yahoo.com Aug 1, 2023 7:00 am
Blueprint Medicines to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023 finance.yahoo.com Jul 19, 2023 8:00 am
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Jul 5, 2023 4:30 pm
NEJM Evidence Publishes Results from Registrational PIONEER Trial Demonstrating Significant Clinical Benefits of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis finance.yahoo.com May 23, 2023 10:00 am
Analysts Estimate Blueprint Medicines (BPMC) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Apr 27, 2023 10:02 am
Blueprint Medicines to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023 finance.yahoo.com Apr 20, 2023 4:01 pm
Blueprint Medicines to Present at Upcoming Investor Conferences finance.yahoo.com Apr 11, 2023 8:00 am
Horizon Therapeutics (HZNP) Down 0.9% Since Last Earnings Report: Can It Rebound? finance.yahoo.com Mar 31, 2023 11:30 am
Blueprint Medicines Announces Lift of Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222 finance.yahoo.com Mar 28, 2023 4:05 pm This company doesn't provide a dividend.
Talk about Blueprint Medicines Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
ir.blueprintmedicines.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 83 HOLD 17 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet